HK Stock MarketDetailed Quotes

02496 YZYBIO-B

Watchlist
  • 4.700
  • 0.0000.00%
Market Closed Apr 30 16:08 CST
911.09MMarket Cap-8.64P/E (TTM)

About YZYBIO-B Company

Wuhan Youzhiyou Biopharmaceutical Co., Ltd. is a biotechnology company dedicated to developing bispecific antibody (BsAb) based therapy for the treatment of cancer-related complications, cancer and senile ophthalmology to address medical needs in the field of oncology and geriatric ophthalmology. The company's mission is to develop innovative medicines to protect human health. Since its establishment in 2010, Youzhibao Biotech has insisted on independent innovation, laid out and deepened the field of bispecific antibodies, and developed 4 innovative platforms, including the self-developed YBODY platform, the Check-body platform, and the nano-YBodyTM platform, and the UVAX platform developed in cooperation with the Wuhan Institute of Virology. The company has designed and developed seven clinical-stage drug candidate pipelines.

Company Profile

Symbol02496
Company NameYZYBIO-B
ISINCNE1000063C4
Listing DateSep 25, 2023
Issue Price16.00
Shares Offered11.00M share(s)
FoundedJul 8, 2010
Registered AddressChina
ChairmanZhou Pengfei
Secretaryjianhualaitianen zheng
Audit InstitutionDeloitte Guan Huang Chen Fang Certified Public Accountants
Company CategoryMainland registration of Mainland Individuals control
Registered Office666 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei, China
Head Office and Principal Place of BusinessRoom 1915, 19th floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees113
MarketHong Kong motherboard
Phone(027)82668988
Fax(027)68788819
Emailinfo@yzybio.com
Business Wuhan YZY Biopharma Co Ltd is a China-based company principally involved in the research, development, production and sales of pharmaceuticals. The Company is suspected in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The Company's drug products are commonly used in major diseases such as tumors, immunity, inflammation and infection.

Company Executives

  • Name
  • Position
  • Salary
  • Zhou Pengfei
  • Chairman, CEOs, Executive Director, Chairman of the Nomination Committee, Co-founder, Authorized Representative
  • --
  • liaoyuan hu
  • Chief Scientific Officer
  • --
  • qian yuan
  • Non-executive Directors, Remuneration Committee Members, Co-founder
  • --
  • hongfeng zhou
  • Non-executive Directors, Audit Committee Members, Co-founder, Authorized Representative
  • --
  • zhenhai pang
  • Non-executive Directors
  • --
  • xiwu hui
  • Non-executive Directors
  • --
  • qian liang
  • Non-executive Directors
  • --
  • zhicheng wen
  • Non-executive Directors
  • --
  • shouwu xie
  • Non-executive Directors
  • --
  • bin cheng
  • Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members
  • --
  • lili fu
  • Independent Non-Executive Director, Chairman of the Audit Committee
  • --
  • yuezhen deng
  • Independent Non-Executive Director, Audit Committee Members
  • --
  • bin chen
  • Independent Non-Executive Director, Nomination Committee Members, Remuneration Committee Members
  • --
  • jumin sun
  • Chairman of the Supervisory Committee
  • --
  • fang liu
  • Auditors
  • --
  • changtao ji
  • Auditors
  • --
  • ying xiao
  • Employee Representative Supervisor
  • --
  • jing zhang
  • Senior Director of R&D Center, auditors
  • --
  • bin yang
  • Vice President of Production Center
  • --
  • shaoyi huang
  • Senior Director of Clinical Division
  • --
  • jianhua zheng
  • Joint Company Secretary
  • --
  • tianen lai
  • Joint Company Secretary
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More